Breaking News Instant updates and real-time market news.

KHC

Kraft Heinz

$87.28

-3.815 (-4.19%)

, CL

Colgate-Palmolive

$72.34

3.34 (4.84%)

09:56
02/17/17
02/17
09:56
02/17/17
09:56

Early notable gainers among liquid option names on February 17th

Notable gainers among liquid option names this morning include Kraft Heinz (KHC) $94.29 +7.03, Colgate Palmolive (CL) $72.17 +3.17, DaVita (DVA) $67.38 +2.74, Kimberly Clark (KMB) $129.96 +3.35, and Clorox (CLX) $133.30 +3.21.

KHC

Kraft Heinz

$87.28

-3.815 (-4.19%)

CL

Colgate-Palmolive

$72.34

3.34 (4.84%)

DVA

DaVita

$66.65

1.99 (3.08%)

KMB

Kimberly-Clark

$130.07

3.45 (2.72%)

CLX

Clorox

$132.91

2.81 (2.16%)

  • 20

    Feb

  • 19

    Mar

KHC Kraft Heinz
$87.28

-3.815 (-4.19%)

02/16/17
SUSQ
02/16/17
DOWNGRADE
SUSQ
Neutral
Kraft Heinz downgraded to Neutral from Positive at Susquehanna
02/15/17
02/15/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Kraft Heinz (KHC) and ConAgra Brands (CAG) were initiated with Buy ratings at Deutsche Bank. The firm also initiated Campbell Soup (CPB), J.M. Smucker (SJM) General Mills (GIS), Hershey (HSY), Kellogg (K) and Mondelez (MDLZ) with a Hold, as well as Pinnacle Foods (PF), Hostess Brands (TWNK) and Snyder's Lance (LNCE) with a Buy. 2. MasterCard (MA) and Visa (V) initiated with Buy ratings at Loop Capital by analyst Joseph Vafi. 3. Bioverativ (BIVV) initiated with an Outperform rating and $56 price target at Leerink by analyst Jason Gerberry. 4. Encana (ECA) initiated with an Overweight at JPMorgan. The firm also reinstated Cheniere Energy (LNG) and Cheniere Energy Partners LP (CQH) with Overweight ratings. 5. Blueprint Medicines (BPMC) initiated with an Overweight at Morgan Stanley by analyst Andrew Berens. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here
02/15/17
DBAB
02/15/17
INITIATION
Target $103
DBAB
Buy
Kraft Heinz initiated with a Buy at Deutsche Bank
Deutsche Bank analyst Rob Dickerson started Kraft Heinz with a Buy rating and $103 price target.
02/13/17
UBSW
02/13/17
NO CHANGE
Target $98
UBSW
Buy
UBS offers three reasons to own Kraft Heinz
UBS analyst Steven Strycula gave three reasons town Kraft Heinz shares. He noted its outsized earnings growth versus peers, the potential to increase its cost savings target, and its ability to increase pricing trends through the rollout of revenue management across its legacy revenue portfolio. Strycula reiterated his Buy rating and $98 price target on Kraft Heinz shares.
CL Colgate-Palmolive
$72.34

3.34 (4.84%)

01/25/17
01/25/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Wal-Mart (WMT) resumed with a Market Perform at Wells Fargo. 2. Colgate-Palmolive (CL) initiated with a Hold at Berenberg. 3. Sysco (SYY) initiated with a Sector Perform at RBC Capital. 4. Carter's (CRI) initiated with an Overweight at Morgan Stanley. 5. American Eagle (AEO) initiated with a Neutral at Buckingham. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/30/17
01/30/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Colgate-Palmolive (CL) downgraded to Neutral from Buy at Citi with analyst Wendy Nicholson saying the sales the "breadth of the top-line weakness" in the company's fourth quarter results is "very disconcerting." Even with the 5% post-earnings pullback, Colgate shares are still not cheap, Nicholson tells investors in a research note. She lowered her price target for the shares to $70 from $76. 2. Air Products (APD) downgraded to Neutral from Outperform at Baird with analyst David Manthey saying he believes the catalyst that led to identifiable margin improvement last quarter may have substantially played out and the company is now more exposed to sluggish economic trends that have underpinned his cautious thinking on Praxair (PX). Manthey lowered his price target to $140 from $146 on Air Products shares. 3. Barclays (BCS) downgraded to Sell from Hold at Berenberg with analyst Peter Richardson citing valuation and high investment banking expectations reflected in shares. 4. Symantec (SYMC) reinstated with a Neutral from Buy at Citi with analyst Walter Pritchard downgrading Symantec (SYMC) to Neutral from Buy after reinstating coverage of the name. The analyst sees "weaker strategic merit" in the company's LifeLock (LOCK) acquisition relative to the Blue Coat deal. He also believes success is being priced in with investors looking for $2.00-plus in earnings power. Pritchard raised his price target for Symantec shares to $29 from $26.50. 5. CONSOL (CNX) downgraded to Hold from Buy at SunTrust. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/25/17
BREN
01/25/17
INITIATION
Target $68
BREN
Hold
Colgate-Palmolive initiated with a Hold at Berenberg
Berenberg analyst Rosie Edwards initiated Colgate-Palmolive with a Hold and a $68 price target citing slowing market shares gains and organic growth.
01/30/17
SBSH
01/30/17
DOWNGRADE
Target $70
SBSH
Neutral
Colgate-Palmolive downgraded to Neutral from Buy at Citi
Citi analyst Wendy Nicholson downgraded Colgate-Palmolive to Neutral saying the sales the "breadth of the top-line weakness" in the company's Q4 results is "very disconcerting." Even with the 5% post-earnings pullback, Colgate shares are still not cheap, Nicholson tells investors in a research note. She lowered her price target for the shares to $70 from $76.
DVA DaVita
$66.65

1.99 (3.08%)

11/01/16
BARD
11/01/16
NO CHANGE
Target $68
BARD
Outperform
DaVita price target lowered to $68 from $85 at Baird
Baird analyst Whit Mayo lowered his price target on DaVita to $68 from $85 following the company's better than feared announcement of its potential $230M hit from on-exchange and off-exchange patients related to a potential CMS ruling regarding charitable premium assistance for ESRD patients. The analyst cut his estimates, although he feels the announcement de-risks the stock. Mayo maintained his Outperform rating on DaVita shares.
12/13/16
BARD
12/13/16
DOWNGRADE
BARD
Neutral
DaVita downgraded to Neutral from Outperform at Baird
12/13/16
12/13/16
DOWNGRADE
Target $69

Neutral
DaVita downgraded to Neutral after CMS guidance at Baird
As previously reported, Baird analyst Whit Mayo downgraded DaVita to Neutral from Outperform after CMS issued its notice with respect to third-party premium support for ESRD patients enrolling in Exchange plans, which he views as potentially putting the company's entire $230M HIX tailwind at risk. Mayo, who also cites the stock's 20% bounce off of its bottom and the company's "tepid" organic growth, sees DaVita shares "trading sideways" in the near-term. He raised his price target on DaVita to $69 from $68.
12/13/16
12/13/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Deutsche Bank analyst Bill Schmitz downgraded Procter & Gamble (PG) to Hold citing a lack of catalysts over the next few quarters. The analyst lowered his price target for P&G shares to $90 from $95 but remains positive on P&G's medium to long-term opportunity. Schmitz also downgraded Coca-Cola (KO) to Hold saying that while CEO James Quincey "is the right person for the turnaround job," near-term stock outperformance will be limited by investor migration out of staples, wellness related consumption headwinds and likely negative earnings revisions. The analyst cut his price target for Coca-Cola shares to $44 from $48. 2. Barclays analyst Karen Short downgraded GNC Holdings (GNC) to Underweight saying the company's recent strategy change and press reports indicating that at least some potential foreign buyers are not interested in the U.S. assets make a potential takeover unlikely. 3. RBC Capital downgraded Viacom (VIAB) to Underperform from Sector Perform after the company announced that it would no longer pursue a merger with CBS (CBS). Wedbush analyst James Dix also downgraded Viacom to Neutral after National Amusements withdrew support for a merger with CBS. 4. Craig-Hallum analyst Chad Bennett downgraded Model N (MODN) to Hold saying the "risks outweigh the benefits" following the company's acquisition of primary competitor Revitas. 5. Baird analyst Whit Mayo downgraded DaVita (DVA) to Neutral from Outperform after CMS issued its notice with respect to third-party premium support for ESRD patients enrolling in Exchange plans, which he views as potentially putting the company's entire $230M HIX tailwind at risk. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
KMB Kimberly-Clark
$130.07

3.45 (2.72%)

10/26/16
LYON
10/26/16
DOWNGRADE
LYON
Underperform
Kimberly-Clark downgraded to Underperform from Outperform at CLSA
01/09/17
LEHM
01/09/17
DOWNGRADE
Target $109
LEHM
Equal Weight
Kimberly-Clark downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Lauren Lieberman downgraded Kimberly-Clark to Equal Weight after lowering her U.S. Non-Food Consumer Staples sector view to Neutral from Positive. The analyst lowered her price target for the shares to $109 from $125. The analyst sees a less favorable macroeconomic backdrop in 2017 and has "fairly muted expectations" for company fundamentals in the space.
11/14/16
WELS
11/14/16
INITIATION
WELS
Market Perform
Kimberly-Clark coverage resumed with a Market Perform at Wells Fargo
Wells Fargo analyst Bonnie Herzog resumed coverage on Kimberly-Clark with a Market Perform and a $117-$119 valuation range.
10/26/16
10/26/16
DOWNGRADE

Underperform
Kimberly-Clark downgraded to Underperform on emerging market weakness at CLSA
As previously reported, CLSA downgraded Kimberly-Clark to Underperform from Outperform and lowered its price target to $116 from $131. Analyst Caroline Levy believes pricing weakness in China will continue as P&G, Kao, and Unicharm, and local competitors compete for share. In the US, she expects P&G to remain aggressive in adult diaper promotions, a key category for Kimberly and said Brazil and Argentina have just begun to weaken. Levy's 2017 and 2018 estimates are below the Street and said a slight contraction in multiple is likely.
CLX Clorox
$132.91

2.81 (2.16%)

01/09/17
LEHM
01/09/17
UPGRADE
Target $111
LEHM
Equal Weight
Clorox upgraded to Equal Weight from Underweight at Barclays
Barclays analyst Lauren Lieberman upgraded Clorox to Equal Weight after lowering her U.S. Non-Food Consumer Staples sector view to Neutral from Positive. The analyst lowered her price target for the shares to $111 from $115.
01/09/17
01/09/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. American Express (AXP) upgraded to Buy from Neutral at BofA/Merrill with analyst Kenneth Bruce saying increased travel and entertainment spending and easing competitive concerns should drive a higher multiple. 2. Dr Pepper Snapple (DPS) upgraded to Neutral from Sell at Goldman with analyst Jason English saying potentially rising rates are a headwind to valuation, expects fundamentals to remain challenged on sluggish end market demand and big brand share challenges, and incremental headwinds from the rising U.S. dollar. 3. Clorox (CLX) upgraded to Equal Weight from Underweight at Barclays with analyst Lauren Lieberman upgrading Clorox to Equal Weight after lowering her U.S. Non-Food Consumer Staples sector view to Neutral from Positive. The analyst lowered her price target for the shares to $111 from $115. 4. JD.com (JD) upgraded to Overweight from Neutral at JPMorgan with analyst Alex Yao citing first-party revenue growth momentum and expectations for a third-party growth recovery in 2017. 5. Cummins (CMI) upgraded to Equal Weight from Underweight at Barclays with analyst Robert Wertheimer saying the company's , share loss may moderate while its capital deployment could drive upside. The analyst raised his price target for the shares to $135 from $108. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/16/16
12/16/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Eli Lilly (LLY) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst David Risinger saying he expects shares to outperform driven by new product growth. 2. General Electric (GE) upgraded to Outperform from Market Perform at Bernstein with analyst Steven Winoker citing valuation and his belief that the company has multiple positive catalysts. 3. Clorox (CLX) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Dara Mohsenian saying valuation is somewhat more compelling given recent underperformance while organic sales growth has improved and potential tax policy changes should be beneficial. 4. ADP (ADP) was upgraded to Conviction Buy from Neutral at Goldman while the firm upgraded Paychex (PAYX) to Buy from Neutral. 5. Sotheby's (BID) upgraded to Outperform from Market Perform at Cowen with analyst Oliver Chen saying he believes the company's transformation under new management is in the early innings and likely to gain momentum next year. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/16/16
12/16/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Apple (AAPL) assumed with an Overweight at Piper Jaffray with analyst Michael Olson assumes coverage of Apple from the departing analyst Gene Munster and keeps an Overweight rating on the shares with a $155 price target. 2. Alphabet (GOOG, GOOGL) initiated with a Neutral at Cleveland Research. 3. Clorox (CLX) initiated with an Outperform at BMO Capital. 4. Biogen (BIIB) initiated with a Neutral at Cantor. 5. Ulta Beauty (ULTA) initiated at BMO Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

03:05
12/14/17
12/14
03:05
12/14/17
03:05
General news
FX Action: USD-CAD ebbed to a six-day low »

FX Action: USD-CAD ebbed…

02:35
12/14/17
12/14
02:35
12/14/17
02:35
General news
FX Update: The dollar turned to consolidation »

FX Update: The dollar…

01:55
12/14/17
12/14
01:55
12/14/17
01:55
General news
FX Action: The USD index (DXY) fell 0.8% »

FX Action: The USD index…

23:00
12/13/17
12/13
23:00
12/13/17
23:00
General news
PBoC nudged rates higher »

PBoC nudged rates higher,…

LPSN

LivePerson

$11.05

-0.05 (-0.45%)

20:28
12/13/17
12/13
20:28
12/13/17
20:28
Initiation
LivePerson initiated at B. Riley FBR »

LivePerson initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

HUSKF

Husky Energy

$12.42

-0.1177 (-0.94%)

20:26
12/13/17
12/13
20:26
12/13/17
20:26
Upgrade
Husky Energy rating change at Goldman Sachs »

Husky Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COP

ConocoPhillips

$51.68

-0.28 (-0.54%)

20:25
12/13/17
12/13
20:25
12/13/17
20:25
Upgrade
ConocoPhillips rating change at Goldman Sachs »

ConocoPhillips upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

SAFM

Sanderson Farms

$167.64

0.64 (0.38%)

20:25
12/13/17
12/13
20:25
12/13/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

DB

Deutsche Bank

$19.33

-0.05 (-0.26%)

19:17
12/13/17
12/13
19:17
12/13/17
19:17
Hot Stocks
DBNY, DBTCA raise prime lending rate to 4.5% from 4.25% »

Deutsche Bank announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$38.04

-0.06 (-0.16%)

18:47
12/13/17
12/13
18:47
12/13/17
18:47
Hot Stocks
AT&T and Communications Workers of America reach tentative agreement »

AT&T Mobility has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$63.47

0.19 (0.30%)

18:33
12/13/17
12/13
18:33
12/13/17
18:33
Hot Stocks
Bristol-Myers granted exclusive license by Ono Pharma to develop ONO-4578 »

Bristol-Myers and Ono…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 05

    Mar

WFC

Wells Fargo

$59.40

-0.93 (-1.54%)

18:15
12/13/17
12/13
18:15
12/13/17
18:15
Hot Stocks
Breaking Hot Stocks news story on Wells Fargo »

Wells Fargo raises prime…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jan

HBAN

Huntington Bancshares

$14.58

-0.23 (-1.55%)

18:10
12/13/17
12/13
18:10
12/13/17
18:10
Hot Stocks
Huntington Bancshares raises prime rate to 4.5% from 4.25% »

Huntington Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASB

Associated Banc-Corp

$25.10

-0.2 (-0.79%)

18:06
12/13/17
12/13
18:06
12/13/17
18:06
Hot Stocks
Breaking Hot Stocks news story on Associated Banc-Corp »

Associated Banc-Corp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UBS

UBS

$17.90

0.035 (0.20%)

18:05
12/13/17
12/13
18:05
12/13/17
18:05
Periodicals
UBS Wealth Management president Zeltner close to stepping down, Bloomberg says »

UBS Wealth Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFE

Pfizer

$36.64

0.06 (0.16%)

18:03
12/13/17
12/13
18:03
12/13/17
18:03
Hot Stocks
Pfizer announces FDA approves IXIFI, a biosimilar to Remicade »

Pfizer announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jan

CNP

CenterPoint Energy

$28.40

0.02 (0.07%)

18:03
12/13/17
12/13
18:03
12/13/17
18:03
Hot Stocks
CenterPoint Energy raises quarterly dividend 4% to 27.75c per share »

CenterPoint Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDXG

MiMedx

$11.99

-0.26 (-2.12%)

18:03
12/13/17
12/13
18:03
12/13/17
18:03
Recommendations
MiMedx analyst commentary at Piper Jaffray »

Piper reiterates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

CE

Celanese

$108.31

1.34 (1.25%)

18:01
12/13/17
12/13
18:01
12/13/17
18:01
Hot Stocks
Celanese raises acetyl intermediates products prices »

Raises price on Vinyl…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAL

Western Alliance

$57.30

-1.25 (-2.13%)

18:01
12/13/17
12/13
18:01
12/13/17
18:01
Hot Stocks
Western Alliance: Sarver to transition from chairman, CEO to exec chairman in Q1 »

Western Alliance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USB

U.S. Bancorp

$54.60

-0.9 (-1.62%)

18:01
12/13/17
12/13
18:01
12/13/17
18:01
Hot Stocks
U.S. Bancorp raises prime lending rate to 4.50% from 4.25%, effective Dec 14 »

U.S. Bancorp last…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

WBS

Webster Financial

$56.16

-0.73 (-1.28%)

18:00
12/13/17
12/13
18:00
12/13/17
18:00
Hot Stocks
Webster raises prime lending rate to 4.5% from 4.25% »

Webster Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

HSBC

HSBC

$51.44

0.89 (1.76%)

17:56
12/13/17
12/13
17:56
12/13/17
17:56
Hot Stocks
Breaking Hot Stocks news story on HSBC »

HSBC raises prime,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WTR

Aqua America

$37.59

0.32 (0.86%)

17:47
12/13/17
12/13
17:47
12/13/17
17:47
Hot Stocks
Aqua America names CEO Christopher Franklin as board chairman »

Aqua America announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

MSFT

Microsoft

$85.35

-0.23 (-0.27%)

17:38
12/13/17
12/13
17:38
12/13/17
17:38
Hot Stocks
Microsoft launches new AI-powered search features for Bing »

Microsoft announced in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.